Goldman Sachs analyst Paul Choi raised the price target on Edgewise Therapeutics (NASDAQ: EWTX) to $32.00 while maintaining a Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE